Cormedix Inc (CRMD)
5.515
+0.26
(+4.85%)
USD |
NASDAQ |
May 01, 16:00
5.515
0.00 (0.00%)
After-Hours: 19:52
Cormedix Cash from Investing (Quarterly): 0.5978M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.5978M |
| September 30, 2023 | -0.5869M |
| June 30, 2023 | -2.386M |
| March 31, 2023 | -14.69M |
| December 31, 2022 | -0.0019M |
| September 30, 2022 | -0.1143M |
| June 30, 2022 | 0.5944M |
| March 31, 2022 | -4.188M |
| December 31, 2021 | -7.129M |
| September 30, 2021 | -1.271M |
| June 30, 2021 | -0.2083M |
| March 31, 2021 | -0.526M |
| December 31, 2020 | -1.848M |
| September 30, 2020 | 3.243M |
| June 30, 2020 | 5.045M |
| March 31, 2020 | 0.9854M |
| December 31, 2019 | 0.2963M |
| September 30, 2019 | -0.4772M |
| June 30, 2019 | -3.875M |
| March 31, 2019 | -7.965M |
| December 31, 2018 | 0.0001M |
| September 30, 2018 | -0.0107M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 1.566M |
| December 31, 2017 | 5.067M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.070M |
| June 30, 2017 | -3.937M |
| March 31, 2017 | 5.158M |
| December 31, 2016 | 4.716M |
| September 30, 2016 | -0.2958M |
| June 30, 2016 | 0.4518M |
| March 31, 2016 | 6.548M |
| December 31, 2015 | 0.01M |
| September 30, 2015 | -10.22M |
| June 30, 2015 | -13.38M |
| March 31, 2015 | -0.0129M |
| December 31, 2014 | 0.0005M |
| September 30, 2014 | -0.0063M |
| June 30, 2014 | -0.0196M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.0357M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.69M
Minimum
Mar 2023
5.045M
Maximum
Jun 2020
-1.397M
Average
-0.4772M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | 0.00 |
| Assertio Holdings Inc | -0.239M |
| Verastem Inc | 12.44M |
| Ocular Therapeutix Inc | -0.459M |
| PAVmed Inc | -0.183M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.75M |
| Cash from Financing (Quarterly) | 0.4677M |
| Free Cash Flow | -38.74M |
| Free Cash Flow Per Share (Quarterly) | -0.1921 |
| Free Cash Flow Yield | -13.81% |